Back to search
Cognitive Impairment Associated With Schizophrenia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cognitive Impairment Associated With Schizophrenia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cognitive Impairment Associated With Schizophrenia trials you may qualify forThis is a Phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) effects of…
Cognitive impairment is well established in people with psychosis and is associated with cannabis use. The current study will investigate the neurobiological ba…
This is a parallel-group randomised-controlled trial aiming to assess the effect of exposure to the arts on mental health and wellbeing of community dwelling re…
This study aims to evaluate the efficacy and safety of TIS targeting the hippocampus in ameliorating cognitive impairment associated with schizophrenia (CIAS).…
The goal of this clinical trial is to evaluate if the investigational drug, RL-007, can improve the cognitive performance of subjects with schizophrenia. The ma…